2025 RET Cancer Research Update
Your investment in The Happy Lungs Project has resulted in very exciting RET lung cancer…
Irene Guijarro MunozDecember 19, 2025
The Role of Biomarker Testing in Early-Stage NSCLC: Why It’s Not Just for Advanced Disease
Advances in biomarker science are reshaping how patients are diagnosed with and manage early-stage lung…
Irene Guijarro MunozDecember 15, 2025
2025 RET Webinar: Meet Our Speakers
The 2025 RET Research Update is just around the corner, and we are excited to…
Irene Guijarro MunozOctober 27, 2025
Join the POISE study at Massachusetts General Hospital
Join the study! Researchers have developed POISE, a short program combining palliative and survivorship care…
Irene Guijarro MunozOctober 23, 2025
RET Studies Presented at the IASLC 2025 World Conference on Lung Cancer
The 2025 IASLC World Conference on Lung Cancer was held in Barcelona, Spain, from September…
Irene Guijarro MunozSeptember 12, 2025
Announcing the Lung Cancer Genetics Study Database
A cancer diagnosis can be life-altering but with access to high-quality, compassionate care, patients can…
Irene Guijarro MunozSeptember 11, 2025
Ellipses’ RET inhibitor EP0031 advances to Phase 2 clinical trials
Ellipses’ next generation selective RET inhibitor EP0031 advances to Phase 2 clinical trials in the…
Irene Guijarro MunozJuly 10, 2025
RET Highlights Presented at the 2025 American Society of Clinical Oncology (ASCO)
RET Highlights Presented at the 2025 American Association for Cancer Research (AACR)
Irene Guijarro MunozJuly 2, 2025
RET Highlights Presented at the 2025 American Association for Cancer Research (AACR)
RET Highlights Presented at the 2025 American Association for Cancer Research (AACR)
Irene Guijarro MunozMay 29, 2025
Cancer Cell Lines: Consider Donating to Advance Research
Donating tumor tissue for research can contribute to scientific progress and help others affected by…
Irene Guijarro MunozMay 21, 2025
